<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE</span><br/>(si-bu'tra-meen)<br/><span class="topboxtradename">Meridia<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">selective serotonin reuptake inhibitor (ssri)</span>; <span class="classification">norepinephrine reuptake inhibitor</span><br/><b>Prototype: </b>Fluoxetine<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg, 15 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Inhibits reuptake of serotonin (5HT<sub>3</sub>), monoamine reuptake, as well as norepinephrine and dopamine reuptake, by blocking their receptors.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Appetite suppression via the mechanism of Meridia. Indicated by a loss of at least 4 lb during the first 4 wk of therapy.</p>
<h1><a name="uses">Uses</a></h1>
<p>Management of obesity, including weight loss and maintenance of weight loss, in patients with BMI of at least 30 kg/m<sup>2</sup> or BMI of at least 27 kg/m<sup>2</sup> and other risk factors (hypertension, diabetes, dyslipidemia).
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Anorexia nervosa; arrhythmias; concurrent administration with other serotonin reuptake inhibitors (e.g., fluoxetine), <small>MAOI</small>s, lithium, tryptophan; severe hepatic or renal impairment; CHF, stroke, CAD; uncontrolled or poorly controlled hypertension;
         pregnancy (category C).
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypertension; older adults; narrow-angle glaucoma; seizures; lactation. Safety and efficacy in patients 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Weight Loss</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 10 mg once daily, preferably in morning, may be increased to 15 mg if inadequate weight loss (</td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>
            				Note: Doses above 15 mg/d are not recommended.
            			
         </li>
<li>Allow at least 2 wk to elapse between discontinuing an <small>MAOI</small>s and starting sibutramine.
         </li>
<li>Store at 15°30° C (59°86° F) in a tightly closed container; protect from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Back pain, flu-like syndrome, asthenia, arthralgia. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache,</span> insomnia, migraine headache, dizziness, nervousness, anxiety, depression, paresthesias, seizures (rare). <span class="typehead">CV:</span> Increase in BP, tachycardia, vasodilation, palpitations. <span class="typehead">GI:</span>
<span class="speceff-common">Dry mouth,</span> anorexia, constipation, abdominal pain, increased appetite, nausea, dyspepsia, taste perversion. <span class="typehead">Respiratory:</span> Rhinitis, pharyngitis, sinusitis, cough. <span class="typehead">Skin:</span> Rash, sweating. <span class="typehead">Urogenital:</span> Dysmenorrhea, UTI. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<span class="classification"> decongestants</span>, <span class="classification">cough and allergy medications</span> may cause additional increase in BP; <span class="classification">maoi</span>s, <span class="classification">ergot derivatives</span>, <b>sumatriptan,</b>
<b>naratriptan,</b>
<b>rizatriptan,</b>
<b>zolmitriptan,</b>
<b>dextromethorphan,</b>
<b>meperidine,</b>
<b>pentazocine,</b>
<b>fentanyl,</b>
<b>lithium;</b>
<span class="classification">ssri</span>s may predispose to <b>serotonin</b> syndrome (see Appendix F); <b>ketoconazole,</b>
<b>erythromycin</b> may inhibit metabolism of sibutramine. <span class="typehead">Herbal:</span>
<b>St. John's wort</b> may cause <b>serotonin</b> syndrome (headache, dizziness, sweating, agitation). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Peak:</span> 1.2 h. <span class="typehead">Distribution:</span> 97% protein bound; concentrates in liver and kidneys. <span class="typehead">Metabolism:</span> Metabolized in liver by cytochrome P450 3A4 to 2 active metabolites. <span class="typehead">Elimination:</span> Excreted primarily in kidneys. <span class="typehead">Half-Life:</span> 1416 h (active metabolites). 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor weight changes carefully to determine therapeutic effect.</li>
<li>Lab tests: Periodic liver function, bilirubin, alkaline phosphatases, lipid profile.</li>
<li>Monitor BR and HR regularly; report sustained increases in BP or HR immediately.</li>
<li>Monitor for and immediately report S&amp;S of serotonin syndrome (see Appendix F).</li>
<li>Monitor persons with narrow-angle glaucoma closely for worsening intraocular pressure.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician if any of the following develop: Rash, hives, or other S&amp;S of an allergic reaction; signs of hyperstimulation
            such as restlessness, shivering, profuse sweating, irritability, and tremor.
         </li>
<li>Take in the morning; causes less interference with sleep.</li>
<li>Check with physician before taking any OTC cough, cold, allergy, or weight-loss drugs.</li>
<li>Maintain strict adherence to prescribed antihypertensives.</li>
<li>Inform physician of all drugs being taken. Serious adverse effects may be experienced with concomitant use of some drugs used
            to treat depression.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>